Global Neuropathic Pain Management Market Research Report 2023

Report ID: 2011388 | Published Date: Jan 2025 | No. of Page: 83 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neuropathic Pain Management Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Tricyclic Antidepressant
        1.2.3 Anticonvulsant
        1.2.4 Opioid
        1.2.5 Steroid Drug
        1.2.6 Local Anesthesia
        1.2.7 Other
    1.3 Market by Application
        1.3.1 Global Neuropathic Pain Management Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Retail Pharmacy
        1.3.3 Hospital Pharmacy
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neuropathic Pain Management Market Perspective (2017-2028)
    2.2 Neuropathic Pain Management Growth Trends by Region
        2.2.1 Neuropathic Pain Management Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neuropathic Pain Management Historic Market Size by Region (2017-2022)
        2.2.3 Neuropathic Pain Management Forecasted Market Size by Region (2023-2028)
    2.3 Neuropathic Pain Management Market Dynamics
        2.3.1 Neuropathic Pain Management Industry Trends
        2.3.2 Neuropathic Pain Management Market Drivers
        2.3.3 Neuropathic Pain Management Market Challenges
        2.3.4 Neuropathic Pain Management Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neuropathic Pain Management Players by Revenue
        3.1.1 Global Top Neuropathic Pain Management Players by Revenue (2017-2022)
        3.1.2 Global Neuropathic Pain Management Revenue Market Share by Players (2017-2022)
    3.2 Global Neuropathic Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neuropathic Pain Management Revenue
    3.4 Global Neuropathic Pain Management Market Concentration Ratio
        3.4.1 Global Neuropathic Pain Management Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Management Revenue in 2021
    3.5 Neuropathic Pain Management Key Players Head office and Area Served
    3.6 Key Players Neuropathic Pain Management Product Solution and Service
    3.7 Date of Enter into Neuropathic Pain Management Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathic Pain Management Breakdown Data by Type
    4.1 Global Neuropathic Pain Management Historic Market Size by Type (2017-2022)
    4.2 Global Neuropathic Pain Management Forecasted Market Size by Type (2023-2028)
5 Neuropathic Pain Management Breakdown Data by Application
    5.1 Global Neuropathic Pain Management Historic Market Size by Application (2017-2022)
    5.2 Global Neuropathic Pain Management Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neuropathic Pain Management Market Size (2017-2028)
    6.2 North America Neuropathic Pain Management Market Size by Country (2017-2022)
    6.3 North America Neuropathic Pain Management Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Neuropathic Pain Management Market Size (2017-2028)
    7.2 Europe Neuropathic Pain Management Market Size by Country (2017-2022)
    7.3 Europe Neuropathic Pain Management Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neuropathic Pain Management Market Size (2017-2028)
    8.2 Asia-Pacific Neuropathic Pain Management Market Size by Country (2017-2022)
    8.3 Asia-Pacific Neuropathic Pain Management Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Neuropathic Pain Management Market Size (2017-2028)
    9.2 Latin America Neuropathic Pain Management Market Size by Country (2017-2022)
    9.3 Latin America Neuropathic Pain Management Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neuropathic Pain Management Market Size (2017-2028)
    10.2 Middle East & Africa Neuropathic Pain Management Market Size by Country (2017-2022)
    10.3 Middle East & Africa Neuropathic Pain Management Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Neuropathic Pain Management Introduction
        11.1.4 Pfizer Revenue in Neuropathic Pain Management Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Johnson & Johnson Services
        11.2.1 Johnson & Johnson Services Company Detail
        11.2.2 Johnson & Johnson Services Business Overview
        11.2.3 Johnson & Johnson Services Neuropathic Pain Management Introduction
        11.2.4 Johnson & Johnson Services Revenue in Neuropathic Pain Management Business (2017-2022)
        11.2.5 Johnson & Johnson Services Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Detail
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Neuropathic Pain Management Introduction
        11.3.4 Sanofi Revenue in Neuropathic Pain Management Business (2017-2022)
        11.3.5 Sanofi Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Neuropathic Pain Management Introduction
        11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Management Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Detail
        11.5.2 Eli Lilly and Company Business Overview
        11.5.3 Eli Lilly and Company Neuropathic Pain Management Introduction
        11.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Management Business (2017-2022)
        11.5.5 Eli Lilly and Company Recent Development
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Detail
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Neuropathic Pain Management Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business (2017-2022)
        11.6.5 Bristol-Myers Squibb Recent Development
    11.7 Biogen Idec
        11.7.1 Biogen Idec Company Detail
        11.7.2 Biogen Idec Business Overview
        11.7.3 Biogen Idec Neuropathic Pain Management Introduction
        11.7.4 Biogen Idec Revenue in Neuropathic Pain Management Business (2017-2022)
        11.7.5 Biogen Idec Recent Development
    11.8 Baxter Healthcare Corporation
        11.8.1 Baxter Healthcare Corporation Company Detail
        11.8.2 Baxter Healthcare Corporation Business Overview
        11.8.3 Baxter Healthcare Corporation Neuropathic Pain Management Introduction
        11.8.4 Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business (2017-2022)
        11.8.5 Baxter Healthcare Corporation Recent Development
    11.9 Depomed
        11.9.1 Depomed Company Detail
        11.9.2 Depomed Business Overview
        11.9.3 Depomed Neuropathic Pain Management Introduction
        11.9.4 Depomed Revenue in Neuropathic Pain Management Business (2017-2022)
        11.9.5 Depomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Neuropathic Pain Management Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Tricyclic Antidepressant
    Table 3. Key Players of Anticonvulsant
    Table 4. Key Players of Opioid
    Table 5. Key Players of Steroid Drug
    Table 6. Key Players of Local Anesthesia
    Table 7. Key Players of Other
    Table 8. Global Neuropathic Pain Management Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Neuropathic Pain Management Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Neuropathic Pain Management Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Neuropathic Pain Management Market Share by Region (2017-2022)
    Table 12. Global Neuropathic Pain Management Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Neuropathic Pain Management Market Share by Region (2023-2028)
    Table 14. Neuropathic Pain Management Market Trends
    Table 15. Neuropathic Pain Management Market Drivers
    Table 16. Neuropathic Pain Management Market Challenges
    Table 17. Neuropathic Pain Management Market Restraints
    Table 18. Global Neuropathic Pain Management Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Neuropathic Pain Management Market Share by Players (2017-2022)
    Table 20. Global Top Neuropathic Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Management as of 2021)
    Table 21. Ranking of Global Top Neuropathic Pain Management Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Neuropathic Pain Management Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Neuropathic Pain Management Product Solution and Service
    Table 25. Date of Enter into Neuropathic Pain Management Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Neuropathic Pain Management Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Neuropathic Pain Management Revenue Market Share by Type (2017-2022)
    Table 29. Global Neuropathic Pain Management Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Neuropathic Pain Management Revenue Market Share by Type (2023-2028)
    Table 31. Global Neuropathic Pain Management Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Neuropathic Pain Management Revenue Market Share by Application (2017-2022)
    Table 33. Global Neuropathic Pain Management Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Neuropathic Pain Management Revenue Market Share by Application (2023-2028)
    Table 35. North America Neuropathic Pain Management Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Neuropathic Pain Management Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Neuropathic Pain Management Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Neuropathic Pain Management Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Neuropathic Pain Management Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Neuropathic Pain Management Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Neuropathic Pain Management Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Neuropathic Pain Management Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Neuropathic Pain Management Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Neuropathic Pain Management Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Pfizer Company Detail
    Table 46. Pfizer Business Overview
    Table 47. Pfizer Neuropathic Pain Management Product
    Table 48. Pfizer Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 49. Pfizer Recent Development
    Table 50. Johnson & Johnson Services Company Detail
    Table 51. Johnson & Johnson Services Business Overview
    Table 52. Johnson & Johnson Services Neuropathic Pain Management Product
    Table 53. Johnson & Johnson Services Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 54. Johnson & Johnson Services Recent Development
    Table 55. Sanofi Company Detail
    Table 56. Sanofi Business Overview
    Table 57. Sanofi Neuropathic Pain Management Product
    Table 58. Sanofi Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 59. Sanofi Recent Development
    Table 60. GlaxoSmithKline Company Detail
    Table 61. GlaxoSmithKline Business Overview
    Table 62. GlaxoSmithKline Neuropathic Pain Management Product
    Table 63. GlaxoSmithKline Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 64. GlaxoSmithKline Recent Development
    Table 65. Eli Lilly and Company Company Detail
    Table 66. Eli Lilly and Company Business Overview
    Table 67. Eli Lilly and Company Neuropathic Pain Management Product
    Table 68. Eli Lilly and Company Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 69. Eli Lilly and Company Recent Development
    Table 70. Bristol-Myers Squibb Company Detail
    Table 71. Bristol-Myers Squibb Business Overview
    Table 72. Bristol-Myers Squibb Neuropathic Pain Management Product
    Table 73. Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 74. Bristol-Myers Squibb Recent Development
    Table 75. Biogen Idec Company Detail
    Table 76. Biogen Idec Business Overview
    Table 77. Biogen Idec Neuropathic Pain Management Product
    Table 78. Biogen Idec Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 79. Biogen Idec Recent Development
    Table 80. Baxter Healthcare Corporation Company Detail
    Table 81. Baxter Healthcare Corporation Business Overview
    Table 82. Baxter Healthcare Corporation Neuropathic Pain Management Product
    Table 83. Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 84. Baxter Healthcare Corporation Recent Development
    Table 85. Depomed Company Detail
    Table 86. Depomed Business Overview
    Table 87. Depomed Neuropathic Pain Management Product
    Table 88. Depomed Revenue in Neuropathic Pain Management Business (2017-2022) & (US$ Million)
    Table 89. Depomed Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuropathic Pain Management Market Share by Type: 2021 VS 2028
    Figure 2. Tricyclic Antidepressant Features
    Figure 3. Anticonvulsant Features
    Figure 4. Opioid Features
    Figure 5. Steroid Drug Features
    Figure 6. Local Anesthesia Features
    Figure 7. Other Features
    Figure 8. Global Neuropathic Pain Management Market Share by Application in 2021 & 2028
    Figure 9. Retail Pharmacy Case Studies
    Figure 10. Hospital Pharmacy Case Studies
    Figure 11. Other Case Studies
    Figure 12. Neuropathic Pain Management Report Years Considered
    Figure 13. Global Neuropathic Pain Management Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Neuropathic Pain Management Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Neuropathic Pain Management Market Share by Region: 2021 VS 2028
    Figure 16. Global Neuropathic Pain Management Market Share by Players in 2021
    Figure 17. Global Top Neuropathic Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Management as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Neuropathic Pain Management Revenue in 2021
    Figure 19. North America Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Neuropathic Pain Management Market Share by Country (2017-2028)
    Figure 21. United States Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Neuropathic Pain Management Market Share by Country (2017-2028)
    Figure 25. Germany Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Neuropathic Pain Management Market Share by Region (2017-2028)
    Figure 33. China Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Neuropathic Pain Management Market Share by Country (2017-2028)
    Figure 41. Mexico Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Neuropathic Pain Management Market Share by Country (2017-2028)
    Figure 45. Turkey Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Neuropathic Pain Management Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Pfizer Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 48. Johnson & Johnson Services Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 49. Sanofi Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 50. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 51. Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 53. Biogen Idec Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 54. Baxter Healthcare Corporation Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 55. Depomed Revenue Growth Rate in Neuropathic Pain Management Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Johnson & Johnson Services
Sanofi
GlaxoSmithKline
Eli Lilly and Company
Bristol-Myers Squibb
Biogen Idec
Baxter Healthcare Corporation
Depomed
Frequently Asked Questions
Neuropathic Pain Management report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuropathic Pain Management report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuropathic Pain Management report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports